Baddour LM, Weiss R, Mark GE, El-Chami MF, Biffi M, Probst V, Lambiase PD, Miller MA, McClernon T, Hansen LK, Knight BP. Diagnosis and management of subcutaneous implantable cardioverter-defibrillator infections based on process mapping.
PACING AND CLINICAL ELECTROPHYSIOLOGY: PACE 2020;
43:958-965. [PMID:
32267974 PMCID:
PMC7607386 DOI:
10.1111/pace.13902]
[Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/16/2019] [Revised: 01/16/2020] [Accepted: 03/02/2020] [Indexed: 01/22/2023]
Abstract
BACKGROUND
Infection is a well-recognized complication of cardiovascular implantable electronic device (CIED) implantation, including the more recently available subcutaneous implantable cardioverter-defibrillator (S-ICD). Although the AHA/ACC/HRS guidelines include recommendations for S-ICD use, currently there are no clinical trial data that address the diagnosis and management of S-ICD infections. Therefore, an expert panel was convened to develop consensus on these topics.
METHODS
A process mapping methodology was used to achieve a primary goal - the development of consensus on the diagnosis and management of S-ICD infections. Two face-to-face meetings of panel experts were conducted to recommend useful information to clinicians in individual patient management of S-ICD infections.
RESULTS
Panel consensus of a stepwise approach in the diagnosis and management was developed to provide guidance in individual patient management.
CONCLUSION
Achieving expert panel consensus by process mapping methodology in S-ICD infection diagnosis and management was attainable, and the results should be helpful in individual patient management.
Collapse